fluphenazine has been researched along with physostigmine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bloss, JL; Singer, GH | 1 |
| Berger, PA; Davis, KL; De Fraites, EG | 1 |
| Jenner, P; Marsden, CD; Rupniak, NM | 1 |
| Allen, RP; Safer, DJ | 1 |
| Furukawa, T; Yamada, K | 1 |
2 review(s) available for fluphenazine and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease Models, Animal; Drug Synergism; Dystonia; Fluphenazine; Haloperidol; Histamine H1 Antagonists; Levodopa; Mastication; Methyltyrosines; Movement Disorders; Parasympatholytics; Physostigmine; Primates; Rats | 1986 |
6 other study(ies) available for fluphenazine and physostigmine
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat.
Topics: Animals; Avoidance Learning; Behavior, Animal; Catalepsy; Clozapine; Dextroamphetamine; Fluphenazine; Haloperidol; Humans; Male; Mice; Motor Activity; Physostigmine; Prostaglandins E; Prostaglandins E, Synthetic; Rats; Stereotyped Behavior; Thioridazine | 1978 |
Coexisting tardive dyskinesia and parkinsonism: a case report.
Topics: Acetylcholine; Adult; Benztropine; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Male; Parkinson Disease, Secondary; Physostigmine; Schizophrenia, Paranoid; Thioridazine; Tranquilizing Agents | 1977 |
The effect of fluphenazine in psychologically normal volunteers: some temporal, performance, and biochemical relationships.
Topics: Adult; Basal Ganglia Diseases; Cholinesterases; Cognition; Dose-Response Relationship, Drug; Fluphenazine; Humans; Injections, Intramuscular; Male; Memory; MMPI; Motor Activity; Motor Skills; Personality; Physostigmine; Time Factors | 1971 |
Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine Antagonists; Fluphenazine; Humans; Male; Parasympathetic Nervous System; Physostigmine; Pilocarpine; Rats; Reflex; Reserpine; Scopolamine; Stereotyped Behavior | 1980 |